Navigation Links
Combating Terrorism with Commercial Technology: 2009 Force Protection Equipment Demonstration
Date:4/23/2009

of the Joint Chiefs of Staff as a result of the bombing at Khobar Towers, in Saudi Arabia, in 1996. He determined there was a need to stay abreast of new counter-terrorism technology by periodically reviewing new or improved equipment available for immediate purchase and employment. The Force Protection Equipment Demonstrations respond to that need and have been held every two years since FPED I in 1997.

The FPED is not a commercial trade show. It is produced by the U.S. Army Product Manager, Force Protection Systems, under sponsorship of the Under Secretary of Defense for Acquisition, Technology and Logistics; the Department of Energy; the Department of Homeland Security; the Joint Staff; the National Institute of Justice; the National Nuclear Security Administration; and the Technical Support Working Group.

The Force Protection Equipment Demonstration is not open to the general public. It is open only to Department of Defense personnel, members of other federal agencies, law enforcement and other first-responder personnel, and media representatives who cover defense, law enforcement and other first-responder operations, management and training. Additional information is available at the event web site: http://www.fped7.org

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.

    EDITORS NOTE:

    Members of the defense, homeland security and first-responder press are encouraged to register as soon as possible at:http://www.fped7.org

    Press parking near the venue entrance is limited. Register now to avoid shuttle.


'/>"/>
SOURCE Force Protection Equipment Demonstration VII
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology news :

1. Hebrew University study opening new route for combating viruses
2. New formula for combating the greenhouse gas nitrous oxide
3. Understanding, combating foodborne pathogens E. coli 0157 and salmonella
4. UNCCD recognizes importance of satellites for combating desertification
5. Demonstration Targets Terrorism
6. Disabled and other vulnerable groups more susceptible to terrorism fears
7. Counter-terrorism symposium held at NJIT tomorrow
8. RAND study finds increase in piracy and terrorism at sea
9. BIO5 researcher identifies cities at risk for terrorism
10. New use for stem cells found in war on terrorism
11. Commercial ships spew half as much particulate pollution as worlds cars
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2015)... , Jul. 13, 2015 NXT-ID, Inc. ... a biometric authentication company focused on the growing ... filed provisional patent 62/188684 for BEHAVIORAL-DIRECTED ... another new convenient and secure method to make ... innovative payment methods, introduced with its groundbreaking voice-direct ...
(Date:7/9/2015)... July 07, 2015 ... addition of the "Biometrics for Banking; Market ... report to their offering. The ... to this growth and the forecast is that ... revenue for companies involved in delivering biometric systems ...
(Date:7/9/2015)... SAN JOSE, Calif. , July 9, ... ), the leading developer of human interface ... authentication technology, the industry,s first fully hardware ... innovative Match-in-Sensor secure authentication technology is literally ... pattern storage and biometric matching within the ...
Breaking Biology News(10 mins):NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 3
... obtaining a three-dimensional model of a protein required ... calculations by hand. Today macromolecular models are built ... particular a package called ARP/wARP. Developed by Victor ... Molecular Biology Laboratory (EMBL) and Anastassis Perrakis at ...
... arrive in Memphis, Tennessee for the Ecological Society of ... state will be presenting the results of their research ... highlights: , Past and present declines in Hemlocks and ... Monday August 7, 5 ?6:30 PM, Exhibit Hall, Cook ...
... have identified a new molecule that inhibits proliferation of ... vitro and in vivo. The findings, published in the ... PI3 kinase family members are most likely to play ... concept that successful small molecule kinase inhibitors must display ...
Cached Biology News:Mapping the protein world 2Ecosystem services and invasive species 2Ecosystem services and invasive species 3Unique dual target specificity of kinase inhibitor key for success against cancer 2
(Date:7/30/2015)... CA (PRWEB) , ... July 30, 2015 , ... ... successful completion of a field clinical study of its canine osteoarthritis stem cell ... with Aratana Therapeutics (Kansas City, KS) and will be marketed in the US ...
(Date:7/30/2015)... , Inc. (NASDAQ: SNMX ), a leading company ... commercialize novel flavor ingredients for the food, beverage, and ... second quarter 2015. "Moving into the ... achieve our commercial and financial goals," stated John Poyhonen, ... our last quarterly earnings report, our two partners have ...
(Date:7/30/2015)... , July 30, 2015 Ascendis Pharma ... that applies its innovative TransCon technology to address ... results from a six-month Phase 2 study to ... Growth Hormone in 53 treatment-naïve, pre-pubertal children with ... are extremely pleased with the top-line results from ...
(Date:7/30/2015)... , July 30, 2015  Discovery Laboratories, Inc. ... has received the second $1.0M tranche under a ... (SBIR) grant valued at up to $3.0 million ... KL4 surfactant as a potential medical countermeasure to ... Labs was awarded an initial $1.0 million under ...
Breaking Biology Technology:VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 2SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 5SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 6SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 7SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 8SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 9Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 2Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 3
... LAWRENCE, Mass., March 31 NxStage Medical,Inc. (Nasdaq: ... dialysis,products, today announced that Tom Shea has joined ... effective March 31, 2008. Mr.,Shea will be responsible ... five manufacturing facilities., Mr. Shea joins NxStage ...
... Reports Financial Results for the 12 Months Ended December ... A/S,(OMX: GEN) announced today results for the financial year ... (approximately USD 104 million) compared to,DKK 136 million (approximately ... of DKK 437 million (approximately USD 86 million).,This compares ...
... Routine and Research ... Applications, ... today its new 600-IR series of FT-IR (Fourier,Transform Infrared) spectrometers, microscopes ... routine analyses and advanced,research applications., FT-IR spectroscopy provides a simple, ...
Cached Biology Technology:NxStage Appoints Tom Shea as Senior Vice President of Manufacturing Operations 2NxStage Appoints Tom Shea as Senior Vice President of Manufacturing Operations 3Genmab Announces Year End 2007 Financial Results 2Genmab Announces Year End 2007 Financial Results 3Genmab Announces Year End 2007 Financial Results 4Genmab Announces Year End 2007 Financial Results 5New FT-IR Spectrometer Series from Varian, Inc. 2
... Helios gene gun system, 220-240 V, is ... into cells. This handheld device employs an ... and other biomaterial-coated gold microcarriers from the ... directly into target cells. This system has ...
Mouse monoclonal antibody raised against a full length recombinant YARS. NCBI Entrez Gene ID = YARS...
Mouse monoclonal antibody raised against a partial recombinant NR4A2. NCBI Entrez Gene ID = NR4A2...
... 300V power supply (Cat. No. Minis 300VS) ... for SDS-PAGE, and native PAGE applications. Furthermore, ... terminator pairs can be used simultaneously. The ... to have his/her own power supply in ...
Biology Products: